Im Oktober dieses Jahres feiert Antares Vision sein 10-jähriges Jubiläum. „In dieser Zeit sind wir von einem Entwickler und Anbieter von Anlagen und Produktionsmaschinen zu einem globalen Anbieter von Komplettlösungen, einschließlich Soft- und Hardware, avanciert“, erklärt Emidio Zorzella, Geschäftsführer von Antares Vision.
With serialization deadlines approaching, the pharmaceutical industry is facing unprecedented challenges. Manufacturers and CMOs are called to action, while competitive opportunities arise from a new approach to supply chain management.
The Open Serialization Communication Standard (Open-SCS) Group, a collection of healthcare sector companies dedicated to standardizing packaging line serialization and aggregation data exchanges, gathered for a three-day meeting at Antares Vision headquarters in Brescia, Italy.
Antares Vision has been awarded an important grant from the European Commission, within the EU Horizon 2020’s SME instrument framework, to develop a new technology for the inspection of lyophilized pharma products for injection (parenteralia) products: the Lyo-Check machine.
Antares Vision’s newest inspection technologies are able to guarantee extraordinary performances both for the improved of the throughput, reaching a speed up to 30,000 bottles/hour and 300,000 tablets/hour. The accuracy of the inspection of the new machine range is also extraordinary, going to detect defects up to 40 μm.
From artificial vision to machines for total inspection to high quality drug tracking technology: The Track & Trace solutions of Antares Vision offer safety and traceability of drug packets for patient protection and in line with the latest regulations.
On January 1, 2012 Turkey became the first country in the world to implement comprehensive legislation on traceability for 100 percent of the medicines sold in its territory. Italian specialist Antares Vision has played a leading role in this transition, equipping more than 40 percent of Turkey’s pharma production lines.